Profile	GDS4890 / AFFX-r2-Bs-thr-M_s_at
Title	Systemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM1256968	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 1	150.263	82
GSM1256969	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 2	124.748	80
GSM1256970	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 3	162.837	83
GSM1256971	SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 4	595.93	94
GSM1256988	Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 55 before YFV	45.2602	68
GSM1256991	Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 55 seven days after YFV	59.1396	71
GSM1256989	Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 56 before YFV	88.158	76
GSM1256992	Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 56 seven days after YFV	64.0778	72
GSM1256990	Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 57 before YFV	56.6053	71
GSM1256993	Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 57 seven days after YFV	52.8833	70